Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
Clinical trial NCT02728752 · COMPLETED
Trial details
- NCT number
- NCT02728752
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2019-11-05
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.